Instrument Inactif

Autres langues VIVUS, Inc.

Actions

VVUSQ

US9285513084

Produits pharmaceutiques

Autres langues

30/04	VIVUS BV Announces Qsiva Price Reduction Across Nordics And Poland
18/03	Vivus BV Confirms QSIVA Price Reduction Is Now Effective Across Nordics And Poland
10/03	Vivus Bv, A Subsidiary of Vivus Llc Announces Qsiva Price Reduction Across Nordics and Poland
26/01	VIVUS LLC Announces the Results of a Randomized Trial Evaluating the Effect of QSYMIA
07/01	VIVUS Introduces Lower Pricing on QSYMIA at Costco Locations Across Hawaii
04/09/25	VIVUS Showcases Leadership in Obesity Management at the 2025 International Congress on Obesity and MEtabolic Syndrome
27/05/25	VIVUS Announces Qsymia Now Available at Costco Pharmacies Nationwide
14/04/25	VIVUS Announces Enrollment of First Patient in Phase 2 Clinical Trial Assessing Ethanol-Free Carmustine as a Component of High-Dose Chemotherapy Prior to Transplant in Patients with Hodgkin or Non-Hodgkin Lymphoma
10/03/25	VIVUS Launches QSYMIA in the United Arab Emirates
23/10/24	VIVUS Announces Label Update for QSYMIA
30/05/24	Vivus, Inc. Announces the Publication of New Clinical Trial Data Demonstrating That Pancreaze Helped to Stabilize Weight in Patients Undergoing Chemotherapy for the Treatment of Pancreatic Ductal Adenocarcinoma
22/04/24	VIVUS LLC Announces It Will Provide Telehealth to Patients Through an Enhanced 'Engage' Program in Collaboration with UpScriptHealth
28/11/23	VIVUS LLC Announces Positive Topline Data from a Post-Marketing Study to Evaluate the Effect of QSYMIA
10/01/23	VIVUS, Inc. Promotes Santosh T. Varghese to President VIVUS Global Pharmaceutical Development
20/07/22	FDA Approves VIVUS LLC's QSYMIA® for the Treatment of Obesity in Adolescents Ages 12-17
14/12/20	VIVUS : Receives Court Approval of Joint Chapter 11 Plan of Reorganization
11/12/20	VIVUS, Inc. Emerged from Bankruptcy
10/12/20	Revised Second Amended Reorganization Plan & Disclosure Statement Approved for VIVUS, Inc.
17/11/20	First Motion for Exclusivity Period Extension Approved For VIVUS, Inc.
16/11/20	VIVUS : Seeks Bankruptcy Court Approval of Second Amended Joint Chapter 11 Plan of Reorganization and Existing Stock Record Date
16/11/20	VIVUS INC : Other Events, Financial Statements and Exhibits (form 8-K)
10/11/20	Second Amended Joint Pre-Packaged Reorganization Plan Filed by VIVUS, Inc.
04/11/20	First Motion for Exclusivity Period Extension Filed by VIVUS, Inc.
20/10/20	Motion for Asset Sale Filed by VIVUS, Inc.
18/08/20	First Amended Joint Pre-Packaged Reorganization Plan Filed by VIVUS, Inc.